2015
DOI: 10.1371/journal.pone.0118154
|View full text |Cite
|
Sign up to set email alerts
|

Conserved Surface Accessible Nucleoside ABC Transporter Component SP0845 Is Essential for Pneumococcal Virulence and Confers Protection In Vivo

Abstract: Streptococcus pneumoniae is a leading cause of bacterial pneumonia, sepsis and meningitis. Surface accessible proteins of S. pneumoniae are being explored for the development of a protein-based vaccine in order to overcome the limitations of existing polysaccharide-based pneumococcal vaccines. To identify a potential vaccine candidate, we resolved surface-associated proteins of S. pneumoniae TIGR4 strain using two-dimensional gel electrophoresis followed by immunoblotting with antisera generated against whole … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
24
0
1

Year Published

2016
2016
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 24 publications
(27 citation statements)
references
References 62 publications
2
24
0
1
Order By: Relevance
“…The proposed ineffectiveness of the immune response to conserved antigens is not consistent with previous work with some SBPs that found evidence that they can be the targets of functional antipneumococcal antibody responses. For example, IgG targeting the ABC transporter lipoproteins PiuA and PiaA can trigger opsonophagocytic activity in human cell lines (63), and immunization of mice with these, or another conserved ABC transporter protein, is protective against invasive (64,65) or respiratory (66) challenge with pneumococci. One study found immunization with the conserved PsaA protein actually elicited better protection against carriage than PspA (67).…”
Section: Discussionmentioning
confidence: 99%
“…The proposed ineffectiveness of the immune response to conserved antigens is not consistent with previous work with some SBPs that found evidence that they can be the targets of functional antipneumococcal antibody responses. For example, IgG targeting the ABC transporter lipoproteins PiuA and PiaA can trigger opsonophagocytic activity in human cell lines (63), and immunization of mice with these, or another conserved ABC transporter protein, is protective against invasive (64,65) or respiratory (66) challenge with pneumococci. One study found immunization with the conserved PsaA protein actually elicited better protection against carriage than PspA (67).…”
Section: Discussionmentioning
confidence: 99%
“…In addition, subcutaneous immunization with recombinant PnrA induced high titers and functional antibodies in mice while these sera were able to promote killing of encapsulated pneumococcal strains in a blood bactericidal assay. Mice immunized with PnrA were protected against heterologous challenge with serotype 3 and serotype 14 strains in a murine sepsis model (Table ) . Thus, PnrA might me a suitable candidate for future vaccines.…”
Section: Immunogenicity and Protective Potential Of Pneumococcal Lipomentioning
confidence: 97%
“…; see also section ‘Pneumococcal lipoproteins as next‐generation vaccine candidates or drug targets’) . Importantly, deletion of pnrA completely abolished virulence of S. pneumoniae type 2 strain D39 and type 4 strain TIGR4 .…”
Section: A General View On the Role Of Pneumococcal Lipoproteins For mentioning
confidence: 97%
See 2 more Smart Citations